LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Announces Pricing of $30.0 Million Public Offering of Common Stock
May 12, 2021 08:30 ET | Recro Pharma, Inc.
EXTON, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
22157.jpg
Global Pharma, Biotech and Diagnostics Asset Purchase Partnering Terms and Agreements Report 2021
May 12, 2021 04:23 ET | Research and Markets
Dublin, May 12, 2021 (GLOBE NEWSWIRE) -- The "Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021" report has been added to ResearchAndMarkets.com's...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Announces Proposed Public Offering of Common Stock
May 11, 2021 16:30 ET | Recro Pharma, Inc.
EXTON, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
U.S. Medical Cannabis Market Projected to Almost Double to Over $16 Billion by 2025
May 11, 2021 10:51 ET | New Frontier Data
Washington, May 11, 2021 (GLOBE NEWSWIRE) -- New Frontier Data (https://NewFrontierData.com), the global authority in data, analytics and business intelligence on the cannabis industry, releases its...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
May 10, 2021 17:29 ET | Catalyst Pharmaceuticals, Inc.
-Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million -Recently Received Orphan Drug Designation for Firdapse® in...
TIP_link_300x300.jpg
Gastrointestinal Drugs Market Growth Sturdy at 4.9% CAGR to Outstrip $71,300.28 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
May 10, 2021 09:30 ET | The Insight Partners
Pune, India., May 10, 2021 (GLOBE NEWSWIRE) -- Gastrointestinal Drugs Market: Key InsightsAccording to our new research study on “Gastrointestinal Drugs Market to 2027 – Global Analysis and Forecast...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021
May 10, 2021 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
TIP_link_300x300.jpg
Dry Eye Products Market Growth Sturdy at 4.8% CAGR to Outstrip $9,141.01 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
May 07, 2021 09:30 ET | The Insight Partners
Pune, India., May 07, 2021 (GLOBE NEWSWIRE) -- Dry Eye Products Market: Key InsightsAccording to our new research study on “Dry Eye Products Market to 2027 – Global Analysis and Forecast – by...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports First Quarter 2021 Financial Results
May 06, 2021 16:05 ET | Recro Pharma, Inc.
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple New Business Agreements Signed Facilities Expansion and Enhancements Continue Company to Host Conference...
ibn-iw-globe-2.png
InvestorBrandNetwork Announces Gamechangers LIVE Interview with XPhyto Therapeutics Corp. CEO and Director Hugh Rogers
May 06, 2021 08:00 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...